Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Osiris Therapeutics Company Profile (NASDAQ:OSIR)

Consensus Ratings for Osiris Therapeutics (NASDAQ:OSIR) (?)
Ratings Breakdown: 2 Sell Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $15.67 (7.45% upside)

Analysts' Ratings History for Osiris Therapeutics (NASDAQ:OSIR)
Show:
DateFirmActionRatingPrice TargetDetailsShare
5/30/2014ZacksUpgradeNeutral -> Outperform$19.00ViewTweet This Rating  Share This Rating on StockTwits
4/11/2014ZacksReiterated RatingNeutral -> Neutral$14.00ViewTweet This Rating  Share This Rating on StockTwits
3/17/2014TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
3/7/2014TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
1/27/2014ZacksDowngradeOutperform -> Neutral$18.00ViewTweet This Rating  Share This Rating on StockTwits
12/6/2013TheStreetUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
11/7/2013ZacksUpgradeNeutral -> Outperform$17.00ViewTweet This Rating  Share This Rating on StockTwits
11/1/2013TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
10/2/2013Piper JaffrayUpgradeNeutral -> Overweight$21.00ViewTweet This Rating  Share This Rating on StockTwits
8/19/2013ZacksReiterated RatingNeutral -> Neutral$20.00ViewTweet This Rating  Share This Rating on StockTwits
8/14/2013Jefferies GroupBoost Price TargetUnderperform$3.00 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
8/13/2013Piper JaffrayDowngradeOverweight -> Neutral$14.00 -> $21.00ViewTweet This Rating  Share This Rating on StockTwits
5/17/2013ZacksDowngradeOutperform -> Neutral$11.00ViewTweet This Rating  Share This Rating on StockTwits
3/28/2013TheStreetUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
3/21/2013ZacksUpgradeNeutral -> Outperform$14.00ViewTweet This Rating  Share This Rating on StockTwits
3/8/2013TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
3/6/2013Piper JaffrayUpgradeNeutral -> OverweightViewTweet This Rating  Share This Rating on StockTwits
1/2/2013ZacksReiterated RatingNeutral -> Neutral$9.50ViewTweet This Rating  Share This Rating on StockTwits
11/8/2012ZacksReiterated RatingNeutral -> Neutral$10.00ViewTweet This Rating  Share This Rating on StockTwits
9/7/2012ZacksReiterated RatingNeutral -> Neutral$9.75ViewTweet This Rating  Share This Rating on StockTwits
8/2/2012ZacksReiterated RatingNeutral -> Neutral$9.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/31/2012 forward)